(Q41331963)

29 September 2017

1 reference

title

Drug treatment of HIV-related opportunistic infections (English)

1 reference

29 September 2017

0 references

Klepser ME

1

1 reference

29 September 2017

Klepser TB

series ordinal

2

1 reference

29 September 2017

publication date

1 January 1997

1 reference

29 September 2017

1 reference

29 September 2017

volume

53

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

40-73

1 reference

Ketoconazole for Treatment of Disseminated Coccidioidomycosis

29 September 2017

cites work

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial.

1 reference

12 December 2020

Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy

1 reference

12 December 2020

Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial

1 reference

12 December 2020

Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature

1 reference

12 December 2020

Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group

1 reference

12 December 2020

Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study

1 reference

12 December 2020

Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis

1 reference

12 December 2020

A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

1 reference

12 December 2020

Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome

1 reference

12 December 2020

Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

1 reference

12 December 2020

Single-dose therapy for esophageal candidiasis with fluconazole.

1 reference

12 December 2020

Antimycobacterial therapy for disseminated Mycobacterium avium complex infection in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group

1 reference

12 December 2020

Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group

1 reference

12 December 2020

The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study.

1 reference

12 December 2020

Treatment of resistant herpes simplex virus with continuous-infusion acyclovir

1 reference

12 December 2020

Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.

1 reference

12 December 2020

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin

1 reference

12 December 2020

Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992.

1 reference

12 December 2020

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

1 reference

12 December 2020

Spectrum of disease in persons with human immunodeficiency virus infection in the United States

1 reference

12 December 2020

1 reference

12 December 2020

Amphotericin B in the treatment of coccidioidomycosis.

1 reference

12 December 2020

The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection

1 reference

12 December 2020

Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Clinical review: progressive disseminated histoplasmosis in the AIDS patient

1 reference

12 December 2020

Treatment of coccidioidal meningitis with fluconazole.

1 reference

12 December 2020

Itraconazole in the treatment of histoplasmosis associated with AIDS.

1 reference

12 December 2020

A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group

1 reference

12 December 2020

Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma.

1 reference

12 December 2020

Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.

1 reference

12 December 2020

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

1 reference

12 December 2020

Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS

1 reference

12 December 2020

A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome

1 reference

12 December 2020

Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team

1 reference

12 December 2020

Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients

1 reference

12 December 2020

Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.

1 reference

12 December 2020

Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma

1 reference

12 December 2020

Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS.

1 reference

12 December 2020

Oral absorption of trimethoprim-sulfamethoxazole in patients with AIDS.

1 reference

12 December 2020

Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis

1 reference

12 December 2020

A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group

1 reference

12 December 2020

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

1 reference

12 December 2020

Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscarnet.

1 reference

12 December 2020

Comparison of multiple drug therapy regimens for HIV-related disseminated Mycobacterium avium complex disease.

1 reference

12 December 2020

Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial

1 reference

12 December 2020

Severe hypersensitivity reactions among HIV-seropositive patients with tuberculosis treated with thioacetazone

1 reference

12 December 2020

Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.

1 reference

12 December 2020

Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study

1 reference

12 December 2020

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection

1 reference

12 December 2020

Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen

1 reference

12 December 2020

Clindamycin/primaquine for treatment of Pneumocystis carinii pneumonia in AIDS.

1 reference

12 December 2020

Disseminated herpes zoster in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients

1 reference

12 December 2020

Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.

1 reference

12 December 2020

Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy

1 reference

12 December 2020

Long-term follow-up of 120 patients with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a

1 reference

12 December 2020

Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS

1 reference

12 December 2020

A double-blind clinical study in patients with herpes zoster to establish YN-72 (Brovavir) dose

1 reference

12 December 2020

Cotrimoxazole therapy of Toxoplasma gondii encephalitis in AIDS patients

1 reference

12 December 2020

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

1 reference

12 December 2020

Continuous infusion of high-dose acyclovir for serious herpesvirus infections

1 reference

12 December 2020

Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison

1 reference

12 December 2020

Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).

1 reference

12 December 2020

Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy.

1 reference

12 December 2020

Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group

1 reference

12 December 2020

Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Pneumocystis pneumonia--Los Angeles

1 reference

12 December 2020

Interferon-??2a in the Treatment of Acquired Immunodeficiency Syndrome-Related Kaposi??s Sarcoma

1 reference

12 December 2020

Safety of alternating ganciclovir and foscarnet maintenance therapy in human immunodeficiency virus (HIV)-related cytomegalovirus infections. An open-labeled pilot study

1 reference

12 December 2020

Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.

1 reference

12 December 2020

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.

1 reference

12 December 2020

Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients

1 reference

12 December 2020

Salvage trial of trimetrexate-leucovorin for the treatment of cerebral toxoplasmosis in patients with AIDS

1 reference

12 December 2020

Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The NIAID-Clinical Center Intramural AIDS Program

1 reference

12 December 2020

Ocular manifestations of acquired immune deficiency syndrome

1 reference

12 December 2020

A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Tuberculosis in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma

1 reference

12 December 2020

Itraconazole therapy for chronic coccidioidal meningitis

1 reference

12 December 2020

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster

1 reference

12 December 2020

Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine

1 reference

12 December 2020

Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group

1 reference

12 December 2020

Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection.

1 reference

12 December 2020

Therapeutic Evaluation of Ketoconazole in Patients with Coccidioidomycosis

1 reference

12 December 2020

Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial

1 reference

12 December 2020

A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma

1 reference

12 December 2020

Clindamycin and Primaquine Therapy for Mild-to-Moderate Episodes of Pneumocystis carinii Pneumonia in Patients with AIDS: AIDS Clinical Trials Group 044

1 reference

12 December 2020

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

12 December 2020

Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS).

1 reference

12 December 2020

Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet).

1 reference

12 December 2020

Control of the body burden of M. avium complex is associated with improved quality of life and prolonged survival of patients with AIDS: a prospective trial with rifabutin combined with isoniazid, clofazimine, ethambutol.

1 reference

12 December 2020

Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis

1 reference

12 December 2020

Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus— and cytomegalovirus-seropositive patients

1 reference

12 December 2020

Single-dose versus 7 days of fluconazole treatment for oral candidiasis in human immunodeficiency virus-infected patients: a prospective, randomized pilot study

1 reference

12 December 2020

Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy

1 reference

12 December 2020

Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group

1 reference

12 December 2020

Clinical effect of BV-araU on varicella-zoster virus infection in immunocompromised patients with haematological malignancies

1 reference

12 December 2020

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

1 reference

12 December 2020

Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS

1 reference

12 December 2020

A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

1 reference

12 December 2020

Ketoconazole for treatment of chronic pulmonary coccidioidomycosis

1 reference

12 December 2020

Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections

1 reference

12 December 2020

Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients

1 reference

12 December 2020

Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.

1 reference

12 December 2020

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

1 reference

12 December 2020

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

1 reference

12 December 2020

Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group

1 reference

12 December 2020

Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients

1 reference

12 December 2020

Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens

1 reference

12 December 2020

Ketoconazole therapy of progressive coccidioidomycosis. Comparison of 400- and 800-mg doses and observations at higher doses

1 reference

12 December 2020

A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

12 December 2020

Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome

1 reference

12 December 2020

Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system

1 reference

12 December 2020

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group

1 reference

12 December 2020

Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS).

1 reference

12 December 2020

Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group

1 reference

12 December 2020

Oral Acyclovir for Treatment of First-Episode Herpes Simplex Virus Proctitis

1 reference

12 December 2020

Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients.

1 reference

12 December 2020

Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome

1 reference

12 December 2020

Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol

1 reference

12 December 2020

Efficacy of triple drug regimen of amikacin, ethambutol and rifabutin in AIDS patients with symptomatic Mycobacterium avium complex infection

1 reference

12 December 2020

Chronic perianal herpes simplex in immunocompromised hosts

1 reference

12 December 2020

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

12 December 2020

Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period

1 reference

12 December 2020

Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone

1 reference

12 December 2020

Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences

1 reference

12 December 2020

Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis

1 reference

12 December 2020

Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data

1 reference

12 December 2020

Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome

1 reference

12 December 2020

Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group

1 reference

12 December 2020

Acute and long-term efficacy of antituberculous treatment in HIV-seropositive patients with tuberculosis: a study of 36 cases.

1 reference

12 December 2020

A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study G

1 reference

12 December 2020

Fluconazole-resistant candidosis in an HIV cohort.

1 reference

12 December 2020

Vidarabine versus acyclovir therapy in herpes simplex encephalitis

1 reference

12 December 2020

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

1 reference

12 December 2020

Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group

1 reference

12 December 2020

Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.

1 reference

12 December 2020

Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study.

1 reference

12 December 2020

Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis

1 reference

12 December 2020

Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS

1 reference

12 December 2020

Prophylactic and suppressive treatment with acyclovir and the management of herpes in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Treatment of Advanced Kaposiʼs Sarcoma Using a Combination of Bleomycin and Vincristine

1 reference

12 December 2020

Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Foscarnet therapy of cytomegalovirus retinitis in AIDS.

1 reference

12 December 2020

Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity

1 reference

12 December 2020

Antiviral therapy of varicella-zoster virus infection in immunocompromised children--a prospective randomized study of aciclovir versus brivudin

1 reference

12 December 2020

The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS

1 reference

12 December 2020

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

1 reference

12 December 2020

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group

1 reference

12 December 2020

Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease

1 reference

12 December 2020

Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151

1 reference

12 December 2020

Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV

1 reference

12 December 2020

Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group

1 reference

12 December 2020

Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients

1 reference

12 December 2020

Pathology of cytomegalovirus retinitis treated with sustained release intravitreal ganciclovir

1 reference

12 December 2020

A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021

1 reference

12 December 2020

Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations

1 reference

12 December 2020

Foscarnet Therapy in Five Patients with AIDS and Acyclovir-resistant Varicella-Zoster Virus Infection

1 reference

12 December 2020

Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group

1 reference

12 December 2020

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

1 reference

12 December 2020

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

1 reference

12 December 2020

10.2165/00003495-199753010-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

29 September 2017

1042567109

0 references

1 reference